myoblast


Also found in: Dictionary, Medical, Wikipedia.

myoblast

[′mī·ə‚blast]
(embryology)
A precursor cell of a muscle fiber.
References in periodicals archive ?
L6 cells showed myotube differentiation with alignment and recognition of myoblasts (Fig.
Coming late spring, early summer 2015 Nubeed Nutrition will be launch Myoblast protein powder and their all new pre-workout Whiplash.
Proliferating satellite cell-derived from all the three muscle depots expressed several myoblast markers, such as MyoD, Myf5, myogenin and desmin, indicating that isolated satellite cells are already committed to the myogenic cell lineage (Grounds et al.
Furthermore, the absence of myogenin reduces MHC expression and myotube formation, indicating that myogenin has a unique function in the transition from a determined myoblast to a fully differentiated myotube (Davie et al.
The researchers knew that a protein called PRDM16 played some part in converting a myoblast into a brown fat cell, but they had a problem.
The myoblast sheets were not transformed into heart muscle, but they apparently released substances that assist the functioning of weakened heart muscles," Sawa told the newspaper.
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
The technique involves obtaining muscle and connective tissue stem cells from a biopsy of the patient's arm and then culturing them for 6 weeks to yield roughly 50 million myoblasts and 50 million fibroblasts.
The grant was related to four of the Company's projects: the Blastomere Program, the Myoblast Program, the RPE Program for Stargardt's Disease, and the iPS Program.
2005) hypothesized that it is possible to transdifferentiate myoblast cells to adipocytes.
Among the topics are myoblast fusion in Drosophila, molecular mechanisms of macrophage fusion, the optical imaging of cell fusion and fusion proteins in the nematode Caenorhabditis elegans, and a sperm-egg fusion assay in mammals.
The company is also concentrating on securing funding for a phase II trial for its myoblast program, an autogolous adult stem cell therapy for the treatment of heart disease, which has successfully completed four phase I clinical trials and has clearance from the Food and Drug Administration to begin phase II trials.